FDA Inspection
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd. – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns Meiji Seika Pharma Co., Ltd., with an inspection on July 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c9e1e8ce-7814-44aa-8c5f-7fb020f0a6e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1065559
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Meiji Seika Pharma Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 3, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Meiji Seika Pharma Co., Ltd.
- FDA Inspection 974522 - 2016-06-03
- FDA Inspection 816790 - 2012-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.